Subscribe to the MEDICI Inner Circle Membership and gain access to an exclusive WhatsApp community where you can engage in discussions with global industry experts!
Symbiont has developed the market-leading platform for institutional applications of blockchain technology. Symbiont smart contracts enable complex instruments to live their entire lifecycle on a truly decentralized, enterprise blockchain network with end-to-end privacy. Institutions are working with Symbiont to develop new business lines, increase transparency, reduce risk, and save costs. Industry leaders such as IPREO, Ranieri and Vanguard have chosen to partner with Symbiont. Headquartered in New York City, Symbiont is a financial technology company founded by a team of experts in capital markets and blockchain technology.
Symbiont was formed as a combination of MathMoney (fx) and Counterparty. It is building a trading & issuance platform – ‘Smart Securities’ (self-executing digital contracts), utilizing the blockchain technology. They issued their first Smart Securities in Aug 2015 with initial use cases – corporate debt, syndicated loans, securitized instruments & private equity.
PRODUCTS & SERVICES
Banks and Government
VALUATION / MARKET CAP:
$46.67 M in 2017
BOARD MEMBERS AND ADVISORS
NUMBER OF EMPLOYEES
Adam Krellenstein(CTO); Mark Smith(CEO)
DATE OF LAST FUNDING
SEED & PRIOR FUNDING
SEED CLOSED ON
SERIES A · $15 M · May 2017
SERIES B · $20 M · Feb 2019
Venture funding: $7 M(Jan 2016)
Sign up for 7 days free trial with MEDICI Inner Circle to follow and track profiles you care about.